glaucoma	is a	chronic eye disease
glaucoma	causes	optic neuropathy
glaucoma	results in	irreversible vision loss
glaucoma	increases	intraocular pressure
glaucoma	damages	optic nerve
glaucoma	leads to	visual field loss
intraocular pressure	is measured by	tonometry
tonometry	measures	intraocular pressure
optic nerve	undergoes	degeneration
glaucoma	is treated with	prostaglandin analogs
latanoprost	is a	prostaglandin analog
latanoprost	reduces	intraocular pressure
timolol	is a	beta-blocker
beta-blockers	lower	intraocular pressure
brimonidine	is a	alpha-2-adrenergic agonist
brimonidine	lowers	intraocular pressure
acetazolamide	is a	carbonic anhydrase inhibitor
dorzolamide	is a	carbonic anhydrase inhibitor
carbonic anhydrase inhibitors	reduce	aqueous humor production
prostaglandin analogs	increase	aqueous outflow
trabeculectomy	is a	surgical procedure
glaucoma drainage device	provides	alternative drainage pathway
Ahmed valve	is a	glaucoma drainage device
Ahmed valve	lowers	intraocular pressure
Baerveldt implant	lowers	intraocular pressure
SLT	is a	laser therapy
selective laser trabeculoplasty	reduces	intraocular pressure
argon laser trabeculoplasty	reduces	intraocular pressure
laser therapy	improves	aqueous outflow
cyclodestructive procedure	reduces	aqueous humor production
neovascular glaucoma	is a	glaucoma subtype
angle-closure glaucoma	is a	glaucoma subtype
open-angle glaucoma	is a	glaucoma subtype
age	is a	risk factor for glaucoma
family history	is a	risk factor for glaucoma
African descent	is a	risk factor for glaucoma
steroid use	increases	glaucoma risk
diabetes	is associated with	glaucoma
hypertension	is associated with	glaucoma
myopia	increases	glaucoma risk
elevated intraocular pressure	increases	glaucoma progression
ocular perfusion pressure	affects	glaucoma progression
optic disc cupping	indicates	glaucoma
cup-to-disc ratio	correlates with	glaucoma severity
visual field defect	is a	feature of glaucoma
OCT	detects	nerve fiber layer thinning
nerve fiber layer thinning	occurs with	glaucoma
perimetry	assesses	visual field
visual field defects	progress with	glaucoma
glaucoma	increases	risk of blindness
systemic hypotension	worsens	glaucoma progression
sleep apnea	increases risk of	glaucoma
pigment dispersion	predisposes to	pigmentary glaucoma
iris	blocks	trabecular meshwork
pigmentary glaucoma	is a	glaucoma subtype
normal tension glaucoma	is a	glaucoma type
ocular hypertension	is a	risk state for glaucoma
topical prostaglandin analogs	are first-line therapy for	open-angle glaucoma
Snellen chart	assesses	visual acuity
dry eye	is a side effect of	prostaglandin analogs
adherence to therapy	influences	glaucoma control
dose timing	affects	efficacy of glaucoma meds
drug interactions	affect	glaucoma meds
glaucoma	requires	chronic follow-up
ophthalmology clinic	monitors	glaucoma management
visual field testing	recommended for	glaucoma monitoring
target intraocular pressure	set for	glaucoma patient
safety profile	varies among	glaucoma medications
systemic hypotension	occurs with	beta-blockers
beta-blockers	cause	bradycardia
acetazolamide	cause	metabolic acidosis
dorzolamide	cause	bitter taste
metabolic acidosis	is a side effect of	acetazolamide
conjunctival hyperemia	is a side effect of	prostaglandin analogs
brimonidine	can cause	dry mouth
neuroprotection	is a focus in	glaucoma research
glaucoma therapy goals	include	preserving vision
visual field preservation	is objective of	glaucoma treatment
quality of life	impacted by	glaucoma
glaucoma management	requires	chronic follow-up
drainage devices	used when	conventional meds fail
glaucoma types	include	open-angle and angle-closure
open-angle glaucoma	is a	chronic progressive condition
angle-closure glaucoma	leads to	acute symptoms
acute angle-closure glaucoma	requires	emergency treatment
SLT	used as	first-line therapy for glaucoma
trabeculectomy	risk of	infection
glaucoma surgery	may fail due to	scarring
neuroprotection strategies	aim to	preserve ganglion cells
ganglion cells	die in	glaucoma
retinal nerve fiber layer thinning	associated with	glaucoma progression
perimetry	monitors	progression of glaucoma
treatment adherence	improves	glaucoma outcomes
education	improves	adherence to therapy
insurance coverage	affects access to	glaucoma care
telemedicine	supports	glaucoma monitoring
mobile apps	assist	glaucoma medication reminders
emergency services	are needed for	acute angle-closure glaucoma
visual disability	risk increases with	chronic glaucoma
annual dilated eye exam	monitors	glaucoma status
